Electromed reported fourth-quarter earnings per share of $0.39, exceeding analyst expectations by $0.08, according to data compiled by Investing.com.
Revenue for the period totaled $19.41 million, falling short of the $19.5 million consensus estimate. The medical device manufacturer, which trades under the ticker ELMD on the NYSE, has seen its stock rise 4.29% over the past three months and 90.42% over the past year.
Electromed’s reported EPS beat follows a period of mixed analyst revisions. In the last 90 days, the company has experienced both upward and downward adjustments to its earnings forecasts. Financial health metrics from InvestingPro currently rate Electromed’s performance as "great performance."
The company’s shares closed at $39.34 on the reporting day.
